A Randomized Phase II Trial of First-Line Treatment with Gemcitabine, Erlotinib, or Gemcitabine and Erlotinib in Elderly Patients (Age >= 70 Years) with Stage IIIB/IV Non-small Cell Lung Cancer Article

cited authors

  • Stinchcombe, Thomas E.; Peterman, Amy H.; Lee, Carrie B.; Moore, Dominic T.; Beaumont, Jennifer L.; Bradford, Daniel S.; Bakri, Kamal; Taylor, Mark; Crane, Jeffrey M.; Schwartz, Garry; Hensing, Thomas A.; McElroy, Edwin, Jr.; Niell, Harvey B.; Harper, Harry D.; Pal, Sridhar; Socinski, Mark A.

authors

Publication Date

  • September 1, 2011

webpage

published in

category

keywords

  • Cumulative illness rating scale for geriatrics
  • Elderly
  • Quality of life
  • Targeted therapy

start page

  • 1569

end page

  • 1577

volume

  • 6

issue

  • 9